[AMPK in the cancer research field: tumor progression by ARK5].
Suzuki
Atsushi
A
National Institute for Physiological Sciences, Division of Endocrinology and Metabolism, 38 Nishigonaka Myodaiji, Okazaki, Aichi 444-8585, Japan.
Esumi
Hiroyasu
H
D055372:AMP-Activated Protein Kinases; D000818:Animals; D003110:Colonic Neoplasms; D018450:Disease Progression; D015195:Drug Design; D006801:Humans; D009097:Multienzyme Complexes / Q000502:physiology*; D009101:Multiple Myeloma; D009361:Neoplasm Invasiveness / Q000235:genetics; D009362:Neoplasm Metastasis / Q000235:genetics; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D011494:Protein Kinases / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D012097:Repressor Proteins / Q000502:physiology*
D009097:Multienzyme Complexes; D012097:Repressor Proteins; D011494:Protein Kinases; C470845:NUAK1 protein, human; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases